These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


514 related items for PubMed ID: 19383082

  • 1. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D, Han KH, Chan HL, Ueno Y, Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [Abstract] [Full Text] [Related]

  • 2. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [Abstract] [Full Text] [Related]

  • 3. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR, Marrero JA.
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [Abstract] [Full Text] [Related]

  • 4. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E, Kuromatsu R, Tanaka M, Takada A, Fukushima N, Sumie S, Nagaoka S, Akiyoshi J, Inoue K, Torimura T, Kumashiro R, Ueno T, Sata M.
    J Clin Gastroenterol; 2006 Aug; 40(10):942-8. PubMed ID: 17063116
    [Abstract] [Full Text] [Related]

  • 5. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, Levy M, Penman AG.
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [Abstract] [Full Text] [Related]

  • 6. [Screening for the early diagnosis of hepatocellular carcinoma: cost-effectiveness analysis].
    Bolondi L, Gaiani S, Casali A, Serra C, Piscaglia F.
    Radiol Med; 1997 May; 94(1-2):4-7. PubMed ID: 9424649
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for hepatocellular carcinoma.
    Merican I.
    Med J Malaysia; 1996 Mar; 51(1):12-7. PubMed ID: 10967973
    [Abstract] [Full Text] [Related]

  • 11. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
    Everson GT.
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
    Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D.
    Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY, Yuwei J R, Angus P, Schelleman T, Johnson L, Gow P.
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
    Cabibbo G, Craxì A.
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):352-5. PubMed ID: 20496547
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.